Histone deacetylase-11 (HDAC11) inhibitors (HDACi) are effective, novel therapy for non-alcoholic steatohapatitis (NASH)

Zhong, Z; Samuvel, D; Foerster, E; Chou, J

TRANSPLANTATION, 2023; 107 (9): 124